(Q43048126)

12 November 2017

title

Immunization with recombinant Calmette-Guerin bacillus (BCG)-hepatitis C virus (HCV) elicits HCV-specific cytotoxic T lymphocytes in mice (English)

1 reference

12 November 2017

0 references

1 reference

8

Yoshiharu Matsuura

1 reference

12 November 2017

Satori Uno-Furuta

1

1 reference

12 November 2017

Kazuhiro Matsuo

2

1 reference

12 November 2017

Shigenori Tamaki

3

1 reference

12 November 2017

Shiki Takamura

4

1 reference

12 November 2017

Akira Kamei

5

1 reference

12 November 2017

Isao Kuromatsu

6

1 reference

12 November 2017

Masahiko Kaito

7

1 reference

12 November 2017

Tatsuo Miyamura

9

1 reference

12 November 2017

Yukihiko Adachi

10

1 reference

12 November 2017

Yasuhiro Yasutomi

11

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

12 November 2017

number of pages

8

1 reference

inferred from page(s)

published in

Vaccine

1 reference

12 November 2017

volume

21

1 reference

12 November 2017

issue

23

1 reference

12 November 2017

page(s)

3149-3156

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Establishment of a human T-cell clone cytotoxic for both autologous and allogeneic hepatocytes from chronic hepatitis patients with type non-A, non-B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

B7/BB-1 expression and hepatitis activity in liver tissues of patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Analysis of a successful immune response against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Analysis of successful immune responses in persons infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Vaccines to prevent viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Induction of virus-specific cytotoxic T lymphocytes by in vivo electric administration of peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

New use of BCG for recombinant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Mycobacterium bovis BCG-induced protection against cutaneous and systemic Leishmania major infections of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Lysogeny and transformation in mycobacteria: stable expression of foreign genes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. V. H-2 associativity of variant-specific antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Real time quantitative PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

MHC ligands and peptide motifs: first listing

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Recent advances with recombinant bacterial vaccine vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Viral vaccination via the mucosal routes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Field trial of oral cholera vaccine in Vietnam.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Long-lasting protective immunity against rodent malaria parasite infection at the blood stage by recombinant BCG secreting merozoite surface protein-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

T-cell subsets required for intravesical BCG immunotherapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Induction of TH1- and TH2-associated cytokine mRNA in mouse bladder following intravesical growth of the murine bladder tumor MB49 and BCG immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Combination gene therapy for liver metastasis of colon carcinoma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Immune responses induced by BCG recombinant for human papillomavirus L1 and E7 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900256-1

7 January 2021

10.1016/S0264-410X(03)00256-1

Identifiers

DOI

1 reference

12 November 2017

1 reference